Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artemether-lumefantrine for P. falciparum Malaria in Brazil
NCT02600767Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Dec 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lumefantrine in malaria, sponsored by Centers for Disease Control and Prevention. Primary endpoint: Absence of Malaria Parasites in Blood at 28 days. Started Dec 2015; status: completed.
02
Drugs
lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02600767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600767.